For eligible patients, GLP-1 receptor agonist therapy (e.g. semaglutide, tirzepatide) can be a powerful tool when prescribed and monitored by an endocrinologist. At BioSlate it is never offered in isolation — it sits inside a nutrition, muscle-preservation and lifestyle plan, with regular monitoring of side effects and blood parameters. Suitability is decided only after consultation.
